Compass Therapeutics (CMPX) executive Lerner bought 10,000 shares for $5,900 at $0.59
Alpha Vantage · Quantisnow · · AI-summarised by FinFlash
Neil Lerner, Chief Accounting Officer at Compass Therapeutics Inc. (CMPX), reported an open-market purchase of 10,000 shares for $5,900 at $0.59 on November 17, 2026. This transaction increased his direct holdings to 430,000 shares. The filing provides details on the transaction, previous holdings, and footnotes regarding unvested restricted stock units.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.